Vasa Therapeutics secures FDA IND clearance to advance VS-041 into clinical trial for HFpEF
IND clearance enables initiation of Phase 1c clinical trial in HFpEF patients with elevated endotrophin levels
IND clearance enables initiation of Phase 1c clinical trial in HFpEF patients with elevated endotrophin levels
The new algorithm will be introduced as part of Roche’s CKD Algorithm Panelon thenavify Algorithm Suite
The company’s largest center for medical device applications, serving the entire Asian market
Wipro’s agents for Agentforce will elevate efficiency and customer satisfaction at healthcare companies
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
GFP is a common fusion protein tag that enables protein expression to be monitored, quantified, and localized within the complex environment of the cell
This Fast Track Designation will enable FDA to review MM-II in an expedited manner, is an important milestone in the development of MM-II
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
Directs officials to ensure that challenges hampering their effective implementation are resolved early in coordination with states
Subscribe To Our Newsletter & Stay Updated